The outlook of companies tied to blockbuster drugs like Viagra presents a complex investment landscape . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the expiry in key markets has introduced significant volatility. Investors are now assessing the effect of lower-cost alternatives,